Gilde Healthcare Holding B.V. is 10% Owner at Inari Medical, Inc. (NARI). They have made 13 open-market trades across 5 companies since 2018, most recently 2026-08-26.
CIK 0001420106
1 open-market purchase totalling $1.3M since 2018, against 12 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NARI | 5,980,747 | $478.3M |
| SI | 2,185,914 | $39.6M |
| EAR | 3,686,075 | $9.5M |
| LVTX | 5,294,178 | $9.2M |
| VAPO | 1,096,526 | $1.4M |
| Total | $538.0M |
Shares reported on the most recent Form 4, priced at the 2026-08-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 58% | 43% |
| Avg Move | -1.4% | -3.9% | +11.4% |
| Scored | 12 | 12 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SI | SELL | 2026-08-26 | 2026-08-28 | $22.60 | $27K | -7.2% | -13.8% | — |
| SI | SELL | 2026-08-20 | 2026-08-24 | $22.61 | $567K | -8.5% | -22.1% | — |
| SI | SELL | 2026-08-03 | 2026-08-05 | $22.76 | $2.5M | -11.7% | -8.4% | — |
| SI | SELL | 2026-07-30 | 2026-08-03 | $23.10 | $1.1M | -14.7% | -8.2% | — |
| LVTX | SELL | 2025-10-08 | 2025-10-10 | $1.56 | $350K | +5.2% | +3.9% | N/A |
| EAR | SELL | 2021-04-23 | 2021-04-27 | $52.65 | $26.1M | -25.2% | -39.2% | -36.8% |
| EAR | SELL | 2021-04-20 | 2021-04-22 | $48.36 | $4.8M | -2.0% | -31.8% | -27.8% |
| EAR | SELL | 2021-04-15 | 2021-04-19 | $48.17 | $916K | +20.5% | -33.0% | -29.1% |
| NARI | SELL | 2020-12-23 | 2020-12-28 | $80.70 | $49.2M | -3.3% | +5.6% | +14.0% |
| NARI | SELL | 2020-12-18 | 2020-12-22 | $74.31 | $101.2M | -2.0% | +32.8% | +41.8% |
| NARI | SELL | 2020-12-10 | 2020-12-14 | $67.58 | $28.0M | +19.6% | +41.2% | +68.4% |
| NARI | SELL | 2020-12-07 | 2020-12-09 | $65.81 | $26.1M | +12.3% | +26.5% | +49.5% |
| VAPO | BUY | 2018-11-16 | 2018-11-20 | $14.00 | $1.3M | +29.4% | +1.3% | +6.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.